# positions[].organizations[].label
Texas A&M University Naresh K. Vashisht College of Medicine

# overview
Dr. Yadav's primary interest is in translational research, specifically biomarker discoveries and novel therapeutics in cancer (especially prostate) through a combination of biochemistry and genomics. He is also interested in mining EMRs for personalized diagnosis, prognosis and therapeutics using real worlds evidence (RWE) data coupled with machine-learning/AI-algorithms.

# keywords[]
4.2 Evaluation Of Markers And Technologies

# keywords[]
4.1 Discovery And Preclinical Testing Of Markers And Technologies

# keywords[]
Psad (prostate Specific Antigen Density)

# keywords[]
Pi-rads (prostate Imaging Reporting And Data System Version 2)

# keywords[]
3102 Bioinformatics And Computational Biology

# keywords[]
Networking And Information Technology R&d (nitrd)

# keywords[]
Machine Learning And Artificial Intelligence

# keywords[]
5 Development Of Treatments And Therapeutic Interventions

# keywords[]
6 Evaluation Of Treatments And Therapeutic Interventions

# keywords[]
Clinical Trials And Supportive Activities

# keywords[]
4.2 Evaluation Of Markers And Technologies

# keywords[]
4.1 Discovery And Preclinical Testing Of Markers And Technologies

# keywords[]
Networking And Information Technology R&d (nitrd)

# keywords[]
Machine Learning And Artificial Intelligence

# keywords[]
5 Development Of Treatments And Therapeutic Interventions

# keywords[]
8.1 Organisation And Delivery Of Services

# keywords[]
Networking And Information Technology R&d (nitrd)

# keywords[]
Machine Learning And Artificial Intelligence

# keywords[]
4.1 Discovery And Preclinical Testing Of Markers And Technologies

# keywords[]
5 Development Of Treatments And Therapeutic Interventions

# keywords[]
6 Evaluation Of Treatments And Therapeutic Interventions

# keywords[]
5 Development Of Treatments And Therapeutic Interventions

# keywords[]
Clinical Trials And Supportive Activities

# educationAndTraining[].organization.label
Memorial Sloan Kettering Cancer Center - (New York, New York, United States)

# educationAndTraining[].organization.label
Indian Institute of Technology Kanpur - (Kanpur, Uttar Pradesh, India)

# educationAndTraining[].organization.label
Banaras Hindu University - (Varanasi, Uttar Pradesh, India)

# educationAndTraining[].organization.label
New York University School of Medicine - (New York, New York, United States)

# publications[].label
GATA2 exosomal mRNA: A novel urine biomarker for the diagnosis of clinically significant prostate cancer.

# publications[].publisher
American Society of Clinical Oncology (ASCO)

# publications[].label
The Use of Biomarkers in Prostate Cancer Screening and Treatment.

# publications[].label
Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer.

# publications[].label
Erratum: Corrigendum: Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome

# publications[].label
Abstract 3772: A multi-scale survey to assess the impact of inflammatory diseases of the abdominal cavity and prostate cancer severity

# publications[].publisher
American Association for Cancer Research (AACR)

# publications[].label
Generation of a Compendium of Transcription Factor Cascades and Identification of Potential Therapeutic Targets using Graph Machine Learning

# publications[].label
Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.

# publications[].label
Epigenetic analysis identifies factors driving racial disparity in prostate cancer

# publications[].label
MP33-09 CLINICAL UTILITY OF PSEUDOURIDINE AS A DIAGNOSTIC MARKER TO DETECT PROSTATE CANCER

# publications[].label
Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications.

# publications[].label
How AI Is Optimizing the Detection and Management of Prostate Cancer.

# publications[].publisher
Institute of Electrical and Electronics Engineers (IEEE)

# publications[].label
MP87-09 DISTINCT EPIGENETIC AND TRANSCRIPTOMIC VARIATIONS IN AFRICAN AMERICAN MEN AS COMPARED TO CAUCASIAN IN PROSTATE CANCER

# publications[].label
Rethinking Teaching Team-Based Learning: The Challenges and Strategies for Medical Education in a Pandemic

# publications[].label
Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level.

# publications[].label
Advances in the Targeted Theragnostics of Osteomyelitis Caused by Staphylococcus aureus

# publications[].label
Development and validation of a polygenic hazard score for aggressive prostate cancer identification.

# publications[].label
Histonefolds: A novel membraneanchoring domain in Son of Sevenless

# publications[].label
Drug-food Interactions in the Era of Molecular Big Data, Machine Intelligence, and Personalized Health.

# publications[].label
PD56-01 COMPARATIVE GENOMIC ANALYSIS OF 1,043 AFRICAN AMERICAN AND NON-AFRICAN AMERICAN PROSTATE CANCERS: A REPORT FROM THE DECIPHER GRID COLLABORATIVE

# publications[].label
Pseudouridine as a novel biomarker in prostate cancer.

# publications[].label
Analysis of real-world data (RWD) on treatment (tx) sequencing in patients with advanced non-small cell lung cancer (aNSCLC).

# publications[].publisher
American Society of Clinical Oncology (ASCO)

# publications[].label
Histologic Changes in Prostate Cancer Detected Subsequent to the 2012 United States Preventive Services Task Force (USPSTF) Prostate Cancer Screening Recommendation.

# publications[].label
An orthosteric inhibitor of the Ras-Sos interaction.

# publications[].label
One-way membrane trafficking of SOS in receptor-triggered Ras activation.

# publications[].label
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.

# publications[].label
Analysis of Real-World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death-1 and Programmed Cell Death-Ligand 1 Inhibitors in Advanced Non-Small Cell Lung Cancers.

# publications[].label
Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.

# publications[].label
Epigenetic analysis identifies factors driving racial disparity in prostate cancer.

# publications[].label
Ubiquitination and deubiquitination: Implications on cancer therapy.

# publications[].label
A Novel Design for a COVID-19 Diagnosis System Using Machine Learning and Drone Technology (COVIDRONE-20)

# publications[].label
Abstract 3250: Computational drug repositioning and biochemical validation of piperlongumine as a potent therapeutic agent for neuroendocrine prostate cancer

# publications[].publisher
American Association for Cancer Research (AACR)

# publications[].label
MP90-11 INDUCTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER CELLS BY DOVITINIB (TKI-258) AND ITS ASSOCIATED THERAPEUTIC IMPLICATIONS

# publications[].label
Advances in the targeted theragnostics of osteomyelitis caused by Staphylococcus aureus.

# publications[].label
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance.

# publications[].label
Systems Medicine Approaches to Improving Understanding, Treatment, and Clinical Management of Neuroendocrine Prostate Cancer.

# publications[].label
Combination effect of therapies targeting the PI3K- and AR-signaling pathways in prostate cancer.

# publications[].label
Intratumor heterogeneity in prostate cancer.

# publications[].label
Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer.

# publications[].label
E-Healthcare Data Management Using Machine Learning and IoT

# publications[].label
Integrated nanoscale deterministic lateral displacement arrays for separation of extracellular vesicles from clinically-relevant volumes of biological samples.

# publications[].label
PD37-10 BIOCHEMICAL VALIDATION OF PIPERLONGUMINE AS A POTENT THERAPEUTIC AGAINST NEUROENDOCRINE PROSTATE CANCER

# publications[].label
MP14-08 A MULTISCALE SURVEY OF INFLAMMATORY DISEASES AND PROSTATE ONCOPHENOTYPES.

# publications[].label
PD32-09 COMBINATION EFFECT OF THERAPIES TARGETING THE PI3K-MTOR AND AR SIGNALING PATHWAYS IN PROSTATE CANCER

# publications[].label
Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death.

# publications[].label
Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment.

# publications[].label
exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids.

# publications[].label
Epigenetic-Metabolic Interplay in the DNA Damage Response and Therapeutic Resistance of Breast Cancer.

# publications[].publisher
American Association for Cancer Research (AACR)

# publications[].label
887P Urine extracellular vesicle GATA2 mRNA alone and in a multigene test predicts initial prostate biopsy result

# publications[].label
Allosteric gating of Son of sevenless activity by the histone domain.

# publications[].publisher
Proceedings of the National Academy of Sciences

# publications[].label
Abstract B023: Identification and biochemical validation of piperlongumine as a potent therapeutic against neuroendocrine prostate cancer

# publications[].publisher
American Association for Cancer Research (AACR)

# publications[].label
Investigating racial differences in treatment responses through analysis of real-world data (RWD).

# publications[].publisher
American Society of Clinical Oncology (ASCO)

# publications[].label
exRNA Signatures in Extracellular Vesicles and their Tumor-Lineage from Prostate Cancer

# publications[].label
Predictive value of pseudouridine in prostate cancer.

# publications[].label
Urine extracellular vesicle GATA2 mRNA alone and in a multigene test predicts initial prostate biopsy result

# organizations[]
Texas A&M University Naresh K. Vashisht College of Medicine